Boston Trust Walden Corp Trims Stake in The Procter & Gamble Company (NYSE:PG)

Boston Trust Walden Corp decreased its stake in shares of The Procter & Gamble Company (NYSE:PG) by 0.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 256,934 shares of the company’s stock after selling 838 shares during the period. Boston Trust Walden Corp’s holdings in Procter & Gamble were worth $43,075,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. Acorn Creek Capital LLC increased its stake in Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after buying an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. increased its position in shares of Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after acquiring an additional 59 shares during the last quarter. Traveka Wealth LLC lifted its stake in shares of Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after acquiring an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC boosted its holdings in Procter & Gamble by 0.7% in the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock valued at $1,507,000 after purchasing an additional 61 shares during the last quarter. Finally, Valued Wealth Advisors LLC grew its stake in Procter & Gamble by 11.2% during the 3rd quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock valued at $105,000 after purchasing an additional 61 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

Shares of PG stock opened at $168.90 on Tuesday. The business has a 50 day simple moving average of $168.34 and a 200 day simple moving average of $169.41. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The firm has a market capitalization of $396.05 billion, a price-to-earnings ratio of 26.90, a price-to-earnings-growth ratio of 3.73 and a beta of 0.45. The Procter & Gamble Company has a 12-month low of $153.52 and a 12-month high of $180.43.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The company had revenue of $21.88 billion for the quarter, compared to analyst estimates of $21.66 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period last year, the company earned $1.84 earnings per share. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. The ex-dividend date is Friday, January 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.17%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on PG shares. Barclays upped their target price on Procter & Gamble from $155.00 to $159.00 and gave the company an “equal weight” rating in a research report on Thursday, January 23rd. UBS Group reduced their price objective on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a research note on Thursday, January 23rd. JPMorgan Chase & Co. decreased their price target on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. Finally, Evercore ISI increased their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $180.53.

Insider Activity at Procter & Gamble

In related news, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the completion of the sale, the insider now directly owns 172,814 shares of the company’s stock, valued at $28,313,845.76. This represents a 34.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the completion of the transaction, the insider now owns 11,595 shares in the company, valued at approximately $2,002,804.35. This trade represents a 52.47 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 151,097 shares of company stock worth $25,635,076 over the last quarter. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.